News Related to BeOne Medicines

Related coverage linked through entity extraction aliases.

Orphan Drug Market Projected to Reach $409 Billion by 2032, Driven by Rare Disease Treatments

Mar 17, 2026

Global orphan drug sales are forecast to reach $409 billion by 2032, representing one-fifth of prescription drug sales, with Johnson & Johnson and Argenx leading the market amid regulatory uncertainty.

Zanubrutinib Shows Superior Efficacy and Persistence Over Other BTK Inhibitors in CLL and B-Cell Lymphomas

Mar 11, 2026

Recent studies demonstrate zanubrutinib delivers higher response rates, longer treatment persistence, and lower healthcare costs compared to acalabrutinib and ibrutinib across multiple B-cell malignancies, with particularly strong benefits in high-risk populations.